← Transmissions
PHARMACOLOGY

Psilocybin Dosage Guide: What Different Amounts Actually Do

June 9, 2026·6 min read

Psilocybin dose is the single most important variable in the experience. The difference between 0.5g and 5g of dried mushrooms is not a matter of degree — it is a difference in kind.

Here is the complete dosage guide and what each range typically produces.

Important Disclaimer

This article is educational information only. Psilocybin mushrooms are a controlled substance in most jurisdictions. These dose ranges are educational references, not instructions or recommendations. Individual response varies significantly. People with personal or family history of psychosis, schizophrenia, or bipolar disorder should not use psilocybin. Consult a medical professional before any psychedelic use.

0.1–0.3g
Typical microdose range — dried mushrooms
25mg
Johns Hopkins high-dose protocol — synthetic psilocybin equivalent
5–10×
Potency variation between mushroom strains — why weight alone is imprecise
2–3.5g
Most common therapeutic dose range in published clinical research

Important caveats before the dosage guide

These ranges apply to dried Psilocybe cubensis — the most commonly available psilocybin mushroom. Other species vary significantly in potency:

  • Psilocybe azurescens and Psilocybe semilanceata are substantially more potent — 2-3 times stronger by weight than P. cubensis
  • Potency varies between individual grows, storage conditions, and specific strain

These ranges are guidelines, not precise predictions. Individual variation in metabolism, sensitivity, and psychological state means the same dose produces meaningfully different experiences in different people — and in the same person at different times.

Always start lower than you think you need.

Microdose — 0.05–0.3g

A microdose is typically defined as a dose too low to produce perceptible psychedelic effects — sub-perceptual. The intention is not an experience but a subtle functional shift.

Reported effects include mild mood elevation, increased focus, enhanced creativity, and reduced anxiety. Effects are typically subtle enough that the person can function normally in work and social contexts.

The evidence for microdosing is mixed. Some trial data supports benefits for mood and focus. Other well-controlled trials have found no significant benefits over placebo. The self-report literature is more positive than the controlled trial literature — suggesting placebo and expectation effects may be significant factors.

Threshold — 0.3–1g

The threshold range begins to produce noticeable perceptual effects while remaining relatively manageable. Colors may appear slightly more vivid. A gentle shift in mood and openness typically occurs. Physical sensations may change slightly.

This is a common starting dose for people exploring for the first time who want to assess their sensitivity without committing to a full experience. Most people find this range comfortable and non-challenging.

Low dose — 1–2g

A low dose produces clearly noticeable effects. Mild visual phenomena, significant mood shift, increased emotional openness, and altered sense of time are typical. Meaningful introspection becomes accessible.

Most healthy adults with appropriate preparation and setting find this range manageable. Challenging experiences are possible but not common.

Medium dose — 2–3.5g

The medium dose range is where most clinical trials conduct their therapeutic work. Effects are significant — clearly psychedelic rather than merely altered, with more pronounced visual phenomena, deeper emotional processing, and beginning of ego softening at the upper end.

Dose Range (dried P. cubensis)Experience TypeTypical EffectsEgo DissolutionTherapeutic Context
0.05–0.3gMicrodoseSubtle mood and focus shift — sub-perceptualNoOngoing research — uncertain
0.3–1gThresholdMild perceptual shift, relaxation, gentle introspectionNoExploratory — low challenge
1–2gLowModerate visuals, mood shift, accessible introspectionRareGentle therapeutic entry
2–3.5gMediumSignificant perceptual change, emotional processing, time distortionSometimes at upper endPrimary therapeutic range in research
3.5–5gHighIntense visuals, ego dissolution common, profound processingCommonDeep therapeutic — experienced users
5g+HeroicFull ego dissolution likely, overwhelming without preparationVery commonAdvanced — full support required

High dose — 3.5–5g

High doses enter territory where ego dissolution — the temporary dissolution of the sense of a separate self — becomes common. This is the range where many people describe their most profound experiences and, for some, their most challenging.

At high doses, the experience may involve complete loss of ordinary reality orientation, encounters with what feels like universal consciousness or vast intelligence, and dissolution of the personal narrative that usually constitutes the felt sense of self.

This range requires thorough preparation, appropriate setting, and ideally a trusted sober companion. It is not appropriate for first-time or inexperienced users.

Heroic dose — 5g+

The term "heroic dose" comes from Terence McKenna, who advocated for 5g or more of dried mushrooms, alone, in complete darkness, as the way to fully engage with what the mushroom offers.

Terence McKenna advocated for what he called the heroic dose — 5g or more of dried mushrooms, alone, in the dark. He believed this was the only way to fully encounter what the mushroom was offering. The clinical research at Johns Hopkins uses a different philosophy: the highest dose that produces a complete mystical experience without being overwhelming. Both approaches reflect genuine philosophies about what the technology is for.

The heroic dose almost certainly produces ego dissolution for most people. It is an extreme experience and should be approached, if at all, only with significant prior experience, thorough preparation, and full support.

The Johns Hopkins doses

The research protocols at Johns Hopkins use synthetic psilocybin, measured in milligrams rather than dried mushroom weight. Their high-dose protocol uses approximately 25mg/70kg — roughly equivalent to 3-4g of dried P. cubensis for an average adult.

Their research produces mystical experiences — documented on validated scales — in a majority of participants at this dose. The protocol includes extensive preparation, structured setting, music, eye shades, and therapist support.

Factors that affect individual response

Body weight: Surprisingly minor factor for psilocybin compared to many other compounds. The common instinct to dose by weight is less relevant than it is for alcohol, for example.

Metabolism: Affects onset timing more than peak intensity. Individual variation exists but is not predictable in advance.

Psychological state: The most significant variable aside from dose. Anxiety, emotional instability, or unresolved psychological material can amplify challenging aspects of the experience at any dose.

Set and setting: At any dose level, the environment and mindset interact with the pharmacological effect to produce the actual experience. The same dose in a supportive therapeutic setting versus an anxious, chaotic setting produces dramatically different experiences.

Read more: The complete psilocybin guide, microdosing science and research, how to prepare, or harm reduction guide.

Share this transmission